Pfizer Inc (PFIZ34) — Working Capital to Net Assets Ratio
Pfizer Inc (PFIZ34) has a Working Capital to Net Assets ratio of 10.2% as of June 2026. Working capital of R$8.71 Billion (current assets of R$41.36 Billion minus current liabilities of R$32.65 Billion) is measured against net assets of R$85.49 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Pfizer Inc (PFIZ34) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Pfizer Inc Working Capital to Net Assets (2014–2025)
This chart shows how Pfizer Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 10.2%, reflecting working capital of R$8.71 Billion against net assets of R$85.49 Billion BRL. For the complete balance sheet picture, see balance sheet size of Pfizer Inc.
Annual Working Capital to Net Assets for Pfizer Inc (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Pfizer Inc from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of Pfizer Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (BRL) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 6.8% | R$5.91 Billion | R$86.78 Billion | R$42.90 Billion | R$36.98 Billion | ▼ -1.5 pp |
| 2024 | 8.3% | R$7.36 Billion | R$88.50 Billion | R$50.36 Billion | R$42.99 Billion | ▲ +13.3 pp |
| 2023 | -5.0% | R$-4.46 Billion | R$89.29 Billion | R$43.33 Billion | R$47.79 Billion | ▼ -14.5 pp |
| 2022 | 9.5% | R$9.12 Billion | R$95.66 Billion | R$51.26 Billion | R$42.14 Billion | ▼ -12.5 pp |
| 2021 | 22.0% | R$17.02 Billion | R$77.20 Billion | R$59.69 Billion | R$42.67 Billion | ▲ +7.6 pp |
| 2020 | 14.5% | R$9.15 Billion | R$63.24 Billion | R$35.07 Billion | R$25.92 Billion | ▲ +21.6 pp |
| 2019 | -7.1% | R$-4.50 Billion | R$63.14 Billion | R$32.80 Billion | R$37.30 Billion | ▼ -35.6 pp |
| 2018 | 28.5% | R$18.07 Billion | R$63.41 Billion | R$49.93 Billion | R$31.86 Billion | ▲ +13.5 pp |
| 2017 | 15.0% | R$10.71 Billion | R$71.31 Billion | R$41.14 Billion | R$30.43 Billion | ▲ +1.9 pp |
| 2016 | 13.2% | R$7.83 Billion | R$59.54 Billion | R$38.95 Billion | R$31.11 Billion | ▼ -9.0 pp |
| 2015 | 22.2% | R$14.41 Billion | R$65.00 Billion | R$43.80 Billion | R$29.40 Billion | ▼ -25.3 pp |
| 2014 | 47.5% | R$34.01 Billion | R$71.62 Billion | R$55.59 Billion | R$21.59 Billion | — |